Global Pharmaceutical Regulatory Affairs Market Trends Report 2023-2024 & 2031: Oncology Segment Dominates, Increasing Demand for Consulting Services, Collaborations to Enhance Market Share
June 28, 2024 04:18 ET
|
Research and Markets
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "Global Pharmaceutical Regulatory Affairs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...
Rentschler Biopharma contributes to nearly 25% of FDA approved biopharmaceuticals in 2023
March 06, 2024 04:00 ET
|
Rentschler Biopharma SE
Exceptional capabilities in guiding therapies from early-stage development through to market based on over 50 years of biotech experience LAUPHEIM, Germany and MILFORD, Mass. and STEVENAGE, United...
Emerging Fanconi Anemia Treatment RP-L102 Drug Insight and Market Forecasts to 2032
January 24, 2024 08:07 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "RP-L102 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. Industry professionals and...
Cell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific Officer
September 28, 2023 08:15 ET
|
CELL-EASY
Cell-Easy, a contract development and manufacturing organization (CDMO) in cell therapy, proudly announces the appointment of Mrs. Gisele Deblandre.
Rentschler Biopharma’s ATMP facility in Stevenage, UK, receives MHRA approval
September 13, 2023 03:00 ET
|
Rentschler Biopharma SE
UK site now set for clinical production of adeno-associated virus (AAV) vectors for gene therapyHighly experienced team ready to support ATMP innovators at all stagesOffering comprehensive range of...
Rentschler Biopharma joins forces with Ikarovec to accelerate novel gene therapies for treatment of ophthalmic disease
June 01, 2023 05:09 ET
|
Rentschler Biopharma SE
Rentschler Biopharma to conduct adeno-associated virus (AAV) process development work for manufacturing scale-up at their ATMP site in Stevenage, UKIkarovec is developing novel gene therapies to treat...
Aseptisches Abfüllen kleiner Volumina bei hoher Präzision
March 09, 2023 09:00 ET
|
Single Use Support
KUFSTEIN, Österreich, March 09, 2023 (GLOBE NEWSWIRE) -- In der Regel erfolgte die Verteilung kleiner Volumina von Arzneimitteln für neuartige Therapien (ATMP) in kleine Einwegbeutel manuell....
Remplissage aseptique de petits volumes haute précision
March 09, 2023 09:00 ET
|
Single Use Support
KUFSTEIN, Autriche, 09 mars 2023 (GLOBE NEWSWIRE) -- Habituellement, la distribution de petits volumes de médicaments de thérapie innovante (ATMP) dans des petits sacs à usage unique s'effectuait...
Aseptic Filling of Small Volumes at High Precision
March 09, 2023 09:00 ET
|
Single Use Support
KUFSTEIN, Austria, March 09, 2023 (GLOBE NEWSWIRE) -- Typically, the distribution of small volumes of advanced therapy medicinal products (ATMP) into small single-use bags was done manually....
nChain Partners With ATMPS Ltd. to Power Their World-Leading Cell and Gene Therapy Platform Hataali
December 06, 2022 07:46 ET
|
nChain (957856)
ZUG, Switzerland, Dec. 06, 2022 (GLOBE NEWSWIRE) -- nChain, one of the largest global blockchain solutions companies, today announces its partnership with Hataali, the world-leading cell and gene...